Aphria Inc. (T:APHA*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 245 Talbot St W Suite 103
LEAMINGTON ON N8H 1N8
Tel: N/A
Website: https://www.aphria.com
IR: See website
<
Key People
Victor Rudolf Neufeld
Chairman of the Board, Chief Executive Officer
Jakob Ripshtein
President
Cole Cacciavillani
Co-Founder and Vice President - Growing operation, Director
John Cervini
Co-Founder and VicePresident-Infrastructure and Technology, Director
Carl A. Merton
Chief Financial Officer
MEGAN Mccrae
Vice President of Marketing
Business Overview
Aphria Inc is a Canada-based company, which is engaged in producing and selling cannabis. Through its subsidiary Broken Coast Cannabis Ltd and Aphria One facility, the Company produces and sells medical and recreational cannabis. Aphria One serves as the basis, on which the Company develops techniques in cultivation, extraction and processing cannabis. The purpose-built, indoor cannabis production facility of Broken Coast Cannabis Ltd provides the Company with B.C. Bud cannabis brand. Broken Coast cannabis is grown on the shores of the Salish Sea in small batches by choice, using single-strain rooms. Through its subsidiary and international organization Aphria International, the Company is focused on building a global cannabis brand. Solei Sungrown Cannabis is the Company's first adult-use brand. The Company has presence in more than 10 countries across 5 continents.
Financial Overview
For the three months ended 31 August 2018, Aphria Inc revenues increased from C$6.1M to C$13.3M. Net income increased 41% to C$21.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Other Non Rec. I/E - Non Business Activ. decrease of 71% to C$2.2M (income), Share-based compensation increase from C$2.5M to C$6.1M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $1,807M as of Aug 31, 2018
Annual revenue (TTM): $44.09M as of Aug 31, 2018
EBITDA (TTM): -$22.50M as of Aug 31, 2018
Net annual income (TTM): $35.58M as of Aug 31, 2018
Free cash flow (TTM): -$266.92M as of Aug 31, 2018
Net Debt Last Fiscal Year: N/A
Shares outstanding: 249,762,289 as of Nov 14, 2018
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization